title: Could PKR inhibition modulate human neurodegeneration?
authors.forename: Jacques
authors.initials: J
authors.lastname: Hugon
authors.forename: Claire
authors.initials: C
authors.lastname: Paquet
authors.forename: Raymond Chuen-Chung
authors.initials: RC
authors.lastname: Chang
mesh_terms: D004789:Enzyme Activation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D015852:Eukaryotic Initiation Factor-2 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D019636:Neurodegenerative Diseases / Q000188:drug therapy* / Q000201:enzymology*; D012694:Serine / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D015852:Eukaryotic Initiation Factor-2; D012694:Serine